Global Genome Engineering Editing Supply, Demand and Key Producers, 2026-2032
The global Genome Engineering Editing market size is expected to reach $ 31660 million by 2032, rising at a market growth of 18.0% CAGR during the forecast period (2026-2032).
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report studies the global Genome Engineering Editing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genome Engineering Editing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Engineering Editing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genome Engineering Editing total market, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Genome Engineering Editing total market, key domestic companies, and share, (USD Million)
Global Genome Engineering Editing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Genome Engineering Editing total market by Type, CAGR, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon?Horizo??n Discovery?, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome Engineering Editing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Genome Engineering Editing Market, By Region:
1. How big is the global Genome Engineering Editing market?
2. What is the demand of the global Genome Engineering Editing market?
3. What is the year over year growth of the global Genome Engineering Editing market?
4. What is the total value of the global Genome Engineering Editing market?
5. Who are the Major Players in the global Genome Engineering Editing market?
6. What are the growth factors driving the market demand?
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report studies the global Genome Engineering Editing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genome Engineering Editing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Engineering Editing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genome Engineering Editing total market, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Genome Engineering Editing total market, key domestic companies, and share, (USD Million)
Global Genome Engineering Editing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Genome Engineering Editing total market by Type, CAGR, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon?Horizo??n Discovery?, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome Engineering Editing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Genome Engineering Editing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CRISPR RNP
- CRISPR mRNA
- CRISPR Virus Delivery
- Others
- RUO
- GMP
- Thermo Fisher Scientific
- SIGMA ALDRICH
- Dharmacon?Horizo??n Discovery?
- Cellectics
- CRISPR Therapeutics
- AstraZeneca
- Bio Rad
- Allele Biotech
- Recombinetics
- Lonza
- Illumina
- Editas Medicine
- Agilent Technologies
- QIAGEN NV
1. How big is the global Genome Engineering Editing market?
2. What is the demand of the global Genome Engineering Editing market?
3. What is the year over year growth of the global Genome Engineering Editing market?
4. What is the total value of the global Genome Engineering Editing market?
5. Who are the Major Players in the global Genome Engineering Editing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Genome Engineering Editing Introduction
1.2 World Genome Engineering Editing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Genome Engineering Editing Total Market by Region (by Headquarter Location)
1.3.1 World Genome Engineering Editing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.3 China Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.4 Europe Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.5 Japan Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.6 South Korea Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.7 ASEAN Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.8 India Based Company Genome Engineering Editing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genome Engineering Editing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Genome Engineering Editing Consumption Value (2021-2032)
2.2 World Genome Engineering Editing Consumption Value by Region
2.2.1 World Genome Engineering Editing Consumption Value by Region (2021-2026)
2.2.2 World Genome Engineering Editing Consumption Value Forecast by Region (2027-2032)
2.3 United States Genome Engineering Editing Consumption Value (2021-2032)
2.4 China Genome Engineering Editing Consumption Value (2021-2032)
2.5 Europe Genome Engineering Editing Consumption Value (2021-2032)
2.6 Japan Genome Engineering Editing Consumption Value (2021-2032)
2.7 South Korea Genome Engineering Editing Consumption Value (2021-2032)
2.8 ASEAN Genome Engineering Editing Consumption Value (2021-2032)
2.9 India Genome Engineering Editing Consumption Value (2021-2032)
3 WORLD GENOME ENGINEERING EDITING COMPANIES COMPETITIVE ANALYSIS
3.1 World Genome Engineering Editing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Genome Engineering Editing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Genome Engineering Editing in 2025
3.2.3 Global Concentration Ratios (CR8) for Genome Engineering Editing in 2025
3.3 Genome Engineering Editing Company Evaluation Quadrant
3.4 Genome Engineering Editing Market: Overall Company Footprint Analysis
3.4.1 Genome Engineering Editing Market: Region Footprint
3.4.2 Genome Engineering Editing Market: Company Product Type Footprint
3.4.3 Genome Engineering Editing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Genome Engineering Editing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Genome Engineering Editing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Genome Engineering Editing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Genome Engineering Editing Consumption Value Comparison
4.2.1 United States VS China: Genome Engineering Editing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Genome Engineering Editing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Genome Engineering Editing Companies and Market Share, 2021-2026
4.3.1 United States Based Genome Engineering Editing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Genome Engineering Editing Revenue, (2021-2026)
4.4 China Based Companies Genome Engineering Editing Revenue and Market Share, 2021-2026
4.4.1 China Based Genome Engineering Editing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Genome Engineering Editing Revenue, (2021-2026)
4.5 Rest of World Based Genome Engineering Editing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Genome Engineering Editing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Genome Engineering Editing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Genome Engineering Editing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 CRISPR RNP
5.2.2 CRISPR mRNA
5.2.3 CRISPR Virus Delivery
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Genome Engineering Editing Market Size by Type (2021-2026)
5.3.2 World Genome Engineering Editing Market Size by Type (2027-2032)
5.3.3 World Genome Engineering Editing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genome Engineering Editing Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 RUO
6.2.2 GMP
6.3 Market Segment by Application
6.3.1 World Genome Engineering Editing Market Size by Application (2021-2026)
6.3.2 World Genome Engineering Editing Market Size by Application (2027-2032)
6.3.3 World Genome Engineering Editing Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific Genome Engineering Editing Product and Services
7.1.4 Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 SIGMA ALDRICH
7.2.1 SIGMA ALDRICH Details
7.2.2 SIGMA ALDRICH Major Business
7.2.3 SIGMA ALDRICH Genome Engineering Editing Product and Services
7.2.4 SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 SIGMA ALDRICH Recent Developments/Updates
7.2.6 SIGMA ALDRICH Competitive Strengths & Weaknesses
7.3 Dharmacon?Horizo??n Discovery?
7.3.1 Dharmacon?Horizo??n Discovery? Details
7.3.2 Dharmacon?Horizo??n Discovery? Major Business
7.3.3 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Services
7.3.4 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Dharmacon?Horizo??n Discovery? Recent Developments/Updates
7.3.6 Dharmacon?Horizo??n Discovery? Competitive Strengths & Weaknesses
7.4 Cellectics
7.4.1 Cellectics Details
7.4.2 Cellectics Major Business
7.4.3 Cellectics Genome Engineering Editing Product and Services
7.4.4 Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Cellectics Recent Developments/Updates
7.4.6 Cellectics Competitive Strengths & Weaknesses
7.5 CRISPR Therapeutics
7.5.1 CRISPR Therapeutics Details
7.5.2 CRISPR Therapeutics Major Business
7.5.3 CRISPR Therapeutics Genome Engineering Editing Product and Services
7.5.4 CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 CRISPR Therapeutics Recent Developments/Updates
7.5.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.6 AstraZeneca
7.6.1 AstraZeneca Details
7.6.2 AstraZeneca Major Business
7.6.3 AstraZeneca Genome Engineering Editing Product and Services
7.6.4 AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 AstraZeneca Recent Developments/Updates
7.6.6 AstraZeneca Competitive Strengths & Weaknesses
7.7 Bio Rad
7.7.1 Bio Rad Details
7.7.2 Bio Rad Major Business
7.7.3 Bio Rad Genome Engineering Editing Product and Services
7.7.4 Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Bio Rad Recent Developments/Updates
7.7.6 Bio Rad Competitive Strengths & Weaknesses
7.8 Allele Biotech
7.8.1 Allele Biotech Details
7.8.2 Allele Biotech Major Business
7.8.3 Allele Biotech Genome Engineering Editing Product and Services
7.8.4 Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Allele Biotech Recent Developments/Updates
7.8.6 Allele Biotech Competitive Strengths & Weaknesses
7.9 Recombinetics
7.9.1 Recombinetics Details
7.9.2 Recombinetics Major Business
7.9.3 Recombinetics Genome Engineering Editing Product and Services
7.9.4 Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Recombinetics Recent Developments/Updates
7.9.6 Recombinetics Competitive Strengths & Weaknesses
7.10 Lonza
7.10.1 Lonza Details
7.10.2 Lonza Major Business
7.10.3 Lonza Genome Engineering Editing Product and Services
7.10.4 Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Lonza Recent Developments/Updates
7.10.6 Lonza Competitive Strengths & Weaknesses
7.11 Illumina
7.11.1 Illumina Details
7.11.2 Illumina Major Business
7.11.3 Illumina Genome Engineering Editing Product and Services
7.11.4 Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Illumina Recent Developments/Updates
7.11.6 Illumina Competitive Strengths & Weaknesses
7.12 Editas Medicine
7.12.1 Editas Medicine Details
7.12.2 Editas Medicine Major Business
7.12.3 Editas Medicine Genome Engineering Editing Product and Services
7.12.4 Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Editas Medicine Recent Developments/Updates
7.12.6 Editas Medicine Competitive Strengths & Weaknesses
7.13 Agilent Technologies
7.13.1 Agilent Technologies Details
7.13.2 Agilent Technologies Major Business
7.13.3 Agilent Technologies Genome Engineering Editing Product and Services
7.13.4 Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Agilent Technologies Recent Developments/Updates
7.13.6 Agilent Technologies Competitive Strengths & Weaknesses
7.14 QIAGEN NV
7.14.1 QIAGEN NV Details
7.14.2 QIAGEN NV Major Business
7.14.3 QIAGEN NV Genome Engineering Editing Product and Services
7.14.4 QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 QIAGEN NV Recent Developments/Updates
7.14.6 QIAGEN NV Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genome Engineering Editing Industry Chain
8.2 Genome Engineering Editing Upstream Analysis
8.3 Genome Engineering Editing Midstream Analysis
8.4 Genome Engineering Editing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Genome Engineering Editing Introduction
1.2 World Genome Engineering Editing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Genome Engineering Editing Total Market by Region (by Headquarter Location)
1.3.1 World Genome Engineering Editing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.3 China Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.4 Europe Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.5 Japan Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.6 South Korea Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.7 ASEAN Based Company Genome Engineering Editing Revenue (2021-2032)
1.3.8 India Based Company Genome Engineering Editing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genome Engineering Editing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Genome Engineering Editing Consumption Value (2021-2032)
2.2 World Genome Engineering Editing Consumption Value by Region
2.2.1 World Genome Engineering Editing Consumption Value by Region (2021-2026)
2.2.2 World Genome Engineering Editing Consumption Value Forecast by Region (2027-2032)
2.3 United States Genome Engineering Editing Consumption Value (2021-2032)
2.4 China Genome Engineering Editing Consumption Value (2021-2032)
2.5 Europe Genome Engineering Editing Consumption Value (2021-2032)
2.6 Japan Genome Engineering Editing Consumption Value (2021-2032)
2.7 South Korea Genome Engineering Editing Consumption Value (2021-2032)
2.8 ASEAN Genome Engineering Editing Consumption Value (2021-2032)
2.9 India Genome Engineering Editing Consumption Value (2021-2032)
3 WORLD GENOME ENGINEERING EDITING COMPANIES COMPETITIVE ANALYSIS
3.1 World Genome Engineering Editing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Genome Engineering Editing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Genome Engineering Editing in 2025
3.2.3 Global Concentration Ratios (CR8) for Genome Engineering Editing in 2025
3.3 Genome Engineering Editing Company Evaluation Quadrant
3.4 Genome Engineering Editing Market: Overall Company Footprint Analysis
3.4.1 Genome Engineering Editing Market: Region Footprint
3.4.2 Genome Engineering Editing Market: Company Product Type Footprint
3.4.3 Genome Engineering Editing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Genome Engineering Editing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Genome Engineering Editing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Genome Engineering Editing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Genome Engineering Editing Consumption Value Comparison
4.2.1 United States VS China: Genome Engineering Editing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Genome Engineering Editing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Genome Engineering Editing Companies and Market Share, 2021-2026
4.3.1 United States Based Genome Engineering Editing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Genome Engineering Editing Revenue, (2021-2026)
4.4 China Based Companies Genome Engineering Editing Revenue and Market Share, 2021-2026
4.4.1 China Based Genome Engineering Editing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Genome Engineering Editing Revenue, (2021-2026)
4.5 Rest of World Based Genome Engineering Editing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Genome Engineering Editing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Genome Engineering Editing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Genome Engineering Editing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 CRISPR RNP
5.2.2 CRISPR mRNA
5.2.3 CRISPR Virus Delivery
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Genome Engineering Editing Market Size by Type (2021-2026)
5.3.2 World Genome Engineering Editing Market Size by Type (2027-2032)
5.3.3 World Genome Engineering Editing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genome Engineering Editing Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 RUO
6.2.2 GMP
6.3 Market Segment by Application
6.3.1 World Genome Engineering Editing Market Size by Application (2021-2026)
6.3.2 World Genome Engineering Editing Market Size by Application (2027-2032)
6.3.3 World Genome Engineering Editing Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific Genome Engineering Editing Product and Services
7.1.4 Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 SIGMA ALDRICH
7.2.1 SIGMA ALDRICH Details
7.2.2 SIGMA ALDRICH Major Business
7.2.3 SIGMA ALDRICH Genome Engineering Editing Product and Services
7.2.4 SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 SIGMA ALDRICH Recent Developments/Updates
7.2.6 SIGMA ALDRICH Competitive Strengths & Weaknesses
7.3 Dharmacon?Horizo??n Discovery?
7.3.1 Dharmacon?Horizo??n Discovery? Details
7.3.2 Dharmacon?Horizo??n Discovery? Major Business
7.3.3 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Services
7.3.4 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Dharmacon?Horizo??n Discovery? Recent Developments/Updates
7.3.6 Dharmacon?Horizo??n Discovery? Competitive Strengths & Weaknesses
7.4 Cellectics
7.4.1 Cellectics Details
7.4.2 Cellectics Major Business
7.4.3 Cellectics Genome Engineering Editing Product and Services
7.4.4 Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Cellectics Recent Developments/Updates
7.4.6 Cellectics Competitive Strengths & Weaknesses
7.5 CRISPR Therapeutics
7.5.1 CRISPR Therapeutics Details
7.5.2 CRISPR Therapeutics Major Business
7.5.3 CRISPR Therapeutics Genome Engineering Editing Product and Services
7.5.4 CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 CRISPR Therapeutics Recent Developments/Updates
7.5.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.6 AstraZeneca
7.6.1 AstraZeneca Details
7.6.2 AstraZeneca Major Business
7.6.3 AstraZeneca Genome Engineering Editing Product and Services
7.6.4 AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 AstraZeneca Recent Developments/Updates
7.6.6 AstraZeneca Competitive Strengths & Weaknesses
7.7 Bio Rad
7.7.1 Bio Rad Details
7.7.2 Bio Rad Major Business
7.7.3 Bio Rad Genome Engineering Editing Product and Services
7.7.4 Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Bio Rad Recent Developments/Updates
7.7.6 Bio Rad Competitive Strengths & Weaknesses
7.8 Allele Biotech
7.8.1 Allele Biotech Details
7.8.2 Allele Biotech Major Business
7.8.3 Allele Biotech Genome Engineering Editing Product and Services
7.8.4 Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Allele Biotech Recent Developments/Updates
7.8.6 Allele Biotech Competitive Strengths & Weaknesses
7.9 Recombinetics
7.9.1 Recombinetics Details
7.9.2 Recombinetics Major Business
7.9.3 Recombinetics Genome Engineering Editing Product and Services
7.9.4 Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Recombinetics Recent Developments/Updates
7.9.6 Recombinetics Competitive Strengths & Weaknesses
7.10 Lonza
7.10.1 Lonza Details
7.10.2 Lonza Major Business
7.10.3 Lonza Genome Engineering Editing Product and Services
7.10.4 Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Lonza Recent Developments/Updates
7.10.6 Lonza Competitive Strengths & Weaknesses
7.11 Illumina
7.11.1 Illumina Details
7.11.2 Illumina Major Business
7.11.3 Illumina Genome Engineering Editing Product and Services
7.11.4 Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Illumina Recent Developments/Updates
7.11.6 Illumina Competitive Strengths & Weaknesses
7.12 Editas Medicine
7.12.1 Editas Medicine Details
7.12.2 Editas Medicine Major Business
7.12.3 Editas Medicine Genome Engineering Editing Product and Services
7.12.4 Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Editas Medicine Recent Developments/Updates
7.12.6 Editas Medicine Competitive Strengths & Weaknesses
7.13 Agilent Technologies
7.13.1 Agilent Technologies Details
7.13.2 Agilent Technologies Major Business
7.13.3 Agilent Technologies Genome Engineering Editing Product and Services
7.13.4 Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Agilent Technologies Recent Developments/Updates
7.13.6 Agilent Technologies Competitive Strengths & Weaknesses
7.14 QIAGEN NV
7.14.1 QIAGEN NV Details
7.14.2 QIAGEN NV Major Business
7.14.3 QIAGEN NV Genome Engineering Editing Product and Services
7.14.4 QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 QIAGEN NV Recent Developments/Updates
7.14.6 QIAGEN NV Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genome Engineering Editing Industry Chain
8.2 Genome Engineering Editing Upstream Analysis
8.3 Genome Engineering Editing Midstream Analysis
8.4 Genome Engineering Editing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF FIGURES
Table 1. World Genome Engineering Editing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Genome Engineering Editing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Genome Engineering Editing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Genome Engineering Editing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Genome Engineering Editing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Genome Engineering Editing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Genome Engineering Editing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Genome Engineering Editing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Genome Engineering Editing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Genome Engineering Editing Players in 2025
Table 12. World Genome Engineering Editing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Genome Engineering Editing Company Evaluation Quadrant
Table 14. Head Office of Key Genome Engineering Editing Players
Table 15. Genome Engineering Editing Market: Company Product Type Footprint
Table 16. Genome Engineering Editing Market: Company Product Application Footprint
Table 17. Genome Engineering Editing Mergers & Acquisitions Activity
Table 18. United States VS China Genome Engineering Editing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Genome Engineering Editing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Genome Engineering Editing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Genome Engineering Editing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Genome Engineering Editing Revenue Market Share (2021-2026)
Table 23. China Based Genome Engineering Editing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Genome Engineering Editing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Genome Engineering Editing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Genome Engineering Editing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Genome Engineering Editing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Genome Engineering Editing Revenue Market Share (2021-2026)
Table 29. World Genome Engineering Editing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Genome Engineering Editing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Genome Engineering Editing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Genome Engineering Editing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Genome Engineering Editing Market Size by Application (2021-2026) & (USD Million)
Table 34. World Genome Engineering Editing Market Size by Application (2027-2032) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Genome Engineering Editing Product and Services
Table 38. Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. SIGMA ALDRICH Basic Information, Manufacturing Base and Competitors
Table 42. SIGMA ALDRICH Major Business
Table 43. SIGMA ALDRICH Genome Engineering Editing Product and Services
Table 44. SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. SIGMA ALDRICH Recent Developments/Updates
Table 46. SIGMA ALDRICH Competitive Strengths & Weaknesses
Table 47. Dharmacon?Horizo??n Discovery? Basic Information, Manufacturing Base and Competitors
Table 48. Dharmacon?Horizo??n Discovery? Major Business
Table 49. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Services
Table 50. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Dharmacon?Horizo??n Discovery? Recent Developments/Updates
Table 52. Dharmacon?Horizo??n Discovery? Competitive Strengths & Weaknesses
Table 53. Cellectics Basic Information, Manufacturing Base and Competitors
Table 54. Cellectics Major Business
Table 55. Cellectics Genome Engineering Editing Product and Services
Table 56. Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Cellectics Recent Developments/Updates
Table 58. Cellectics Competitive Strengths & Weaknesses
Table 59. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. CRISPR Therapeutics Major Business
Table 61. CRISPR Therapeutics Genome Engineering Editing Product and Services
Table 62. CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CRISPR Therapeutics Recent Developments/Updates
Table 64. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 65. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 66. AstraZeneca Major Business
Table 67. AstraZeneca Genome Engineering Editing Product and Services
Table 68. AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. AstraZeneca Recent Developments/Updates
Table 70. AstraZeneca Competitive Strengths & Weaknesses
Table 71. Bio Rad Basic Information, Manufacturing Base and Competitors
Table 72. Bio Rad Major Business
Table 73. Bio Rad Genome Engineering Editing Product and Services
Table 74. Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Bio Rad Recent Developments/Updates
Table 76. Bio Rad Competitive Strengths & Weaknesses
Table 77. Allele Biotech Basic Information, Manufacturing Base and Competitors
Table 78. Allele Biotech Major Business
Table 79. Allele Biotech Genome Engineering Editing Product and Services
Table 80. Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Allele Biotech Recent Developments/Updates
Table 82. Allele Biotech Competitive Strengths & Weaknesses
Table 83. Recombinetics Basic Information, Manufacturing Base and Competitors
Table 84. Recombinetics Major Business
Table 85. Recombinetics Genome Engineering Editing Product and Services
Table 86. Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Recombinetics Recent Developments/Updates
Table 88. Recombinetics Competitive Strengths & Weaknesses
Table 89. Lonza Basic Information, Manufacturing Base and Competitors
Table 90. Lonza Major Business
Table 91. Lonza Genome Engineering Editing Product and Services
Table 92. Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Lonza Recent Developments/Updates
Table 94. Lonza Competitive Strengths & Weaknesses
Table 95. Illumina Basic Information, Manufacturing Base and Competitors
Table 96. Illumina Major Business
Table 97. Illumina Genome Engineering Editing Product and Services
Table 98. Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Illumina Recent Developments/Updates
Table 100. Illumina Competitive Strengths & Weaknesses
Table 101. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 102. Editas Medicine Major Business
Table 103. Editas Medicine Genome Engineering Editing Product and Services
Table 104. Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Editas Medicine Recent Developments/Updates
Table 106. Editas Medicine Competitive Strengths & Weaknesses
Table 107. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Agilent Technologies Major Business
Table 109. Agilent Technologies Genome Engineering Editing Product and Services
Table 110. Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Agilent Technologies Recent Developments/Updates
Table 112. Agilent Technologies Competitive Strengths & Weaknesses
Table 113. QIAGEN NV Basic Information, Manufacturing Base and Competitors
Table 114. QIAGEN NV Major Business
Table 115. QIAGEN NV Genome Engineering Editing Product and Services
Table 116. QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. QIAGEN NV Recent Developments/Updates
Table 118. QIAGEN NV Competitive Strengths & Weaknesses
Table 119. Global Key Players of Genome Engineering Editing Upstream (Raw Materials)
Table 120. Global Genome Engineering Editing Typical Customers
LIST OF FIGURES
Figure 1. Genome Engineering Editing Picture
Figure 2. World Genome Engineering Editing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Genome Engineering Editing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Genome Engineering Editing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Genome Engineering Editing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 13. Genome Engineering Editing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Genome Engineering Editing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Genome Engineering Editing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Genome Engineering Editing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Genome Engineering Editing Markets in 2025
Figure 27. United States VS China: Genome Engineering Editing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Genome Engineering Editing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Genome Engineering Editing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Genome Engineering Editing Market Size Market Share by Type in 2025
Figure 31. CRISPR RNP
Figure 32. CRISPR mRNA
Figure 33. CRISPR Virus Delivery
Figure 34. Others
Figure 35. World Genome Engineering Editing Market Size Market Share by Type (2021-2032)
Figure 36. World Genome Engineering Editing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 37. World Genome Engineering Editing Market Size Market Share by Application in 2025
Figure 38. RUO
Figure 39. GMP
Figure 40. World Genome Engineering Editing Market Size Market Share by Application (2021-2032)
Figure 41. Genome Engineering Editing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Genome Engineering Editing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Genome Engineering Editing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Genome Engineering Editing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Genome Engineering Editing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Genome Engineering Editing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Genome Engineering Editing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Genome Engineering Editing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Genome Engineering Editing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Genome Engineering Editing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Genome Engineering Editing Players in 2025
Table 12. World Genome Engineering Editing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Genome Engineering Editing Company Evaluation Quadrant
Table 14. Head Office of Key Genome Engineering Editing Players
Table 15. Genome Engineering Editing Market: Company Product Type Footprint
Table 16. Genome Engineering Editing Market: Company Product Application Footprint
Table 17. Genome Engineering Editing Mergers & Acquisitions Activity
Table 18. United States VS China Genome Engineering Editing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Genome Engineering Editing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Genome Engineering Editing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Genome Engineering Editing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Genome Engineering Editing Revenue Market Share (2021-2026)
Table 23. China Based Genome Engineering Editing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Genome Engineering Editing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Genome Engineering Editing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Genome Engineering Editing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Genome Engineering Editing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Genome Engineering Editing Revenue Market Share (2021-2026)
Table 29. World Genome Engineering Editing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Genome Engineering Editing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Genome Engineering Editing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Genome Engineering Editing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Genome Engineering Editing Market Size by Application (2021-2026) & (USD Million)
Table 34. World Genome Engineering Editing Market Size by Application (2027-2032) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Genome Engineering Editing Product and Services
Table 38. Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. SIGMA ALDRICH Basic Information, Manufacturing Base and Competitors
Table 42. SIGMA ALDRICH Major Business
Table 43. SIGMA ALDRICH Genome Engineering Editing Product and Services
Table 44. SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. SIGMA ALDRICH Recent Developments/Updates
Table 46. SIGMA ALDRICH Competitive Strengths & Weaknesses
Table 47. Dharmacon?Horizo??n Discovery? Basic Information, Manufacturing Base and Competitors
Table 48. Dharmacon?Horizo??n Discovery? Major Business
Table 49. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Services
Table 50. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Dharmacon?Horizo??n Discovery? Recent Developments/Updates
Table 52. Dharmacon?Horizo??n Discovery? Competitive Strengths & Weaknesses
Table 53. Cellectics Basic Information, Manufacturing Base and Competitors
Table 54. Cellectics Major Business
Table 55. Cellectics Genome Engineering Editing Product and Services
Table 56. Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Cellectics Recent Developments/Updates
Table 58. Cellectics Competitive Strengths & Weaknesses
Table 59. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. CRISPR Therapeutics Major Business
Table 61. CRISPR Therapeutics Genome Engineering Editing Product and Services
Table 62. CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CRISPR Therapeutics Recent Developments/Updates
Table 64. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 65. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 66. AstraZeneca Major Business
Table 67. AstraZeneca Genome Engineering Editing Product and Services
Table 68. AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. AstraZeneca Recent Developments/Updates
Table 70. AstraZeneca Competitive Strengths & Weaknesses
Table 71. Bio Rad Basic Information, Manufacturing Base and Competitors
Table 72. Bio Rad Major Business
Table 73. Bio Rad Genome Engineering Editing Product and Services
Table 74. Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Bio Rad Recent Developments/Updates
Table 76. Bio Rad Competitive Strengths & Weaknesses
Table 77. Allele Biotech Basic Information, Manufacturing Base and Competitors
Table 78. Allele Biotech Major Business
Table 79. Allele Biotech Genome Engineering Editing Product and Services
Table 80. Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Allele Biotech Recent Developments/Updates
Table 82. Allele Biotech Competitive Strengths & Weaknesses
Table 83. Recombinetics Basic Information, Manufacturing Base and Competitors
Table 84. Recombinetics Major Business
Table 85. Recombinetics Genome Engineering Editing Product and Services
Table 86. Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Recombinetics Recent Developments/Updates
Table 88. Recombinetics Competitive Strengths & Weaknesses
Table 89. Lonza Basic Information, Manufacturing Base and Competitors
Table 90. Lonza Major Business
Table 91. Lonza Genome Engineering Editing Product and Services
Table 92. Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Lonza Recent Developments/Updates
Table 94. Lonza Competitive Strengths & Weaknesses
Table 95. Illumina Basic Information, Manufacturing Base and Competitors
Table 96. Illumina Major Business
Table 97. Illumina Genome Engineering Editing Product and Services
Table 98. Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Illumina Recent Developments/Updates
Table 100. Illumina Competitive Strengths & Weaknesses
Table 101. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 102. Editas Medicine Major Business
Table 103. Editas Medicine Genome Engineering Editing Product and Services
Table 104. Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Editas Medicine Recent Developments/Updates
Table 106. Editas Medicine Competitive Strengths & Weaknesses
Table 107. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Agilent Technologies Major Business
Table 109. Agilent Technologies Genome Engineering Editing Product and Services
Table 110. Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Agilent Technologies Recent Developments/Updates
Table 112. Agilent Technologies Competitive Strengths & Weaknesses
Table 113. QIAGEN NV Basic Information, Manufacturing Base and Competitors
Table 114. QIAGEN NV Major Business
Table 115. QIAGEN NV Genome Engineering Editing Product and Services
Table 116. QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. QIAGEN NV Recent Developments/Updates
Table 118. QIAGEN NV Competitive Strengths & Weaknesses
Table 119. Global Key Players of Genome Engineering Editing Upstream (Raw Materials)
Table 120. Global Genome Engineering Editing Typical Customers
LIST OF FIGURES
Figure 1. Genome Engineering Editing Picture
Figure 2. World Genome Engineering Editing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Genome Engineering Editing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Genome Engineering Editing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Genome Engineering Editing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Genome Engineering Editing Revenue (2021-2032) & (USD Million)
Figure 13. Genome Engineering Editing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Genome Engineering Editing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Genome Engineering Editing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Genome Engineering Editing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Genome Engineering Editing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Genome Engineering Editing Markets in 2025
Figure 27. United States VS China: Genome Engineering Editing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Genome Engineering Editing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Genome Engineering Editing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Genome Engineering Editing Market Size Market Share by Type in 2025
Figure 31. CRISPR RNP
Figure 32. CRISPR mRNA
Figure 33. CRISPR Virus Delivery
Figure 34. Others
Figure 35. World Genome Engineering Editing Market Size Market Share by Type (2021-2032)
Figure 36. World Genome Engineering Editing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 37. World Genome Engineering Editing Market Size Market Share by Application in 2025
Figure 38. RUO
Figure 39. GMP
Figure 40. World Genome Engineering Editing Market Size Market Share by Application (2021-2032)
Figure 41. Genome Engineering Editing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
